Fulgent Genetics (FLGT) Depreciation & Amortization (CF) (2016 - 2025)
Fulgent Genetics' Depreciation & Amortization (CF) history spans 10 years, with the latest figure at $6.1 million for Q4 2025.
- For Q4 2025, Depreciation & Amortization (CF) fell 1.29% year-over-year to $6.1 million; the TTM value through Dec 2025 reached $24.1 million, down 3.23%, while the annual FY2025 figure was $24.1 million, 3.23% down from the prior year.
- Depreciation & Amortization (CF) for Q4 2025 was $6.1 million at Fulgent Genetics, up from $6.0 million in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $9.8 million in Q3 2022 and bottomed at $1.9 million in Q1 2021.
- The 5-year median for Depreciation & Amortization (CF) is $6.1 million (2024), against an average of $5.9 million.
- The largest annual shift saw Depreciation & Amortization (CF) skyrocketed 355.37% in 2021 before it crashed 34.63% in 2023.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $3.5 million in 2021, then soared by 180.78% to $9.8 million in 2022, then plummeted by 33.35% to $6.5 million in 2023, then dropped by 5.22% to $6.2 million in 2024, then fell by 1.29% to $6.1 million in 2025.
- Per Business Quant, the three most recent readings for FLGT's Depreciation & Amortization (CF) are $6.1 million (Q4 2025), $6.0 million (Q3 2025), and $6.1 million (Q2 2025).